Clinical Trials Directory

Trials / Conditions / Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

9 registered clinical trials studyying Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingValidation of a Patient Knowledge Questionnaire for Pulmonary Hypertension
NCT07120789
University of Sao Paulo General HospitalN/A
RecruitingRutgers University Study of the Genetics of Pulmonary Hypertension
NCT07217522
Rutgers, The State University of New Jersey—
RecruitingThe Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension
NCT07013149
University of Sao Paulo General Hospital—
RecruitingPulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch
NCT06998329
University of Sao Paulo General Hospital—
WithdrawnA Phase 2 Study of IkT-001Pro in Pulmonary Arterial Hypertension (PAH)
NCT06643143
Inhibikase TherapeuticsPhase 2
CompletedIncorporating the Venous Excess Ultrasound Score (VExUS Score) Into Contemporary Haemodynamic Risk Assessment
NCT07266012
Istanbul University - Cerrahpasa—
RecruitingimprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce
NCT06850792
University of Sao Paulo General HospitalN/A
CompletedThe Effect of Slow-Paced Breathing on Patient Outcomes in Pulmonary Arterial Hypertension
NCT07232368
Ege UniversityN/A
CompletedClinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Correspon
NCT03904693
ActelionPhase 3